Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002480941 | SCV002790889 | pathogenic | Autosomal recessive nonsyndromic hearing loss 28 | 2022-03-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003151847 | SCV003840753 | pathogenic | not provided | 2022-09-16 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28000701, 34416374, 28089734) |
Labcorp Genetics |
RCV003151847 | SCV004300010 | pathogenic | not provided | 2023-11-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu1154Alafs*29) in the TRIOBP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TRIOBP are known to be pathogenic (PMID: 16385457, 16385458, 20510926). This variant is present in population databases (rs771696726, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with nonsyndromic deafness (PMID: 28000701, 28089734, 34416374). This variant is also known as c.3456_3457delCT (p.Asp1152AspfsTer31). ClinVar contains an entry for this variant (Variation ID: 996725). For these reasons, this variant has been classified as Pathogenic. |
University of Washington Center for Mendelian Genomics, |
RCV001291491 | SCV001479995 | likely pathogenic | Hearing loss, autosomal recessive | no assertion criteria provided | research |